Clinical Trials Browser

Phase 1/2 × INDUSTRY × depatuxizumab × Clear all

NCT02590263 2020-09-03

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

Phase 1/2 Completed

Glioblastoma, Glioma, Lymphoma, Follicular